Abstract
Bone marrow transplantation (BMT) has been used increasingly to treat patients with various hematological diseases. It is one method of overcoming dose-limiting myelosuppression, thereby allowing the administration of otherwise lethal doses of chemotherapy, total body irradition, or both. At the University of Essen a BMT program was instituted in December 1975. The current survey will review the results in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic myeloid leukemia (CML).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Molls M, Bamberg M, Beelen DW, Mahmoud HK, Quast U, Schaefer UW (1987) Different TBI procedures in Essen: results and clinical considerations on the risk of leukemic relapse and interstitial pneumonitis. Strahlenther Onkol 163:237–240
Beelen DW, Quabeck K, Graeven U, Sayer HG, Mahmoud HK, Schaefer UW (1989) Acute toxicity and first clinical results of intensive postinduction therapy using a modified Busulfan and Cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia. Blood 74:1507–1516
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schaefer, U.W. (1993). Bone Marrow Transplantation in Acute Leukemias and Chronic Myeloid Leukemia. In: Fleischer, J. (eds) Leukemias. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77083-8_34
Download citation
DOI: https://doi.org/10.1007/978-3-642-77083-8_34
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77085-2
Online ISBN: 978-3-642-77083-8
eBook Packages: Springer Book Archive